Company Information

Headquarters
United States
Founded in
2012
Employees
Speciality
Alzheimer'sneuroscienceAlzheimer's disease
Overview
Cortexyme is a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer’s and other degenerative diseases. Cortexyme is targeting a specific pathogen found in the brain of Alzheimer’s patients that causes neurodegeneration and other pathology in animal models. Cortexyme’s lead small molecule, atuzaginstat (COR388), has advanced through Phase Ib and is currently the subject of a Phase 2/3 GAIN clinical trial in mild to moderate Alzheimer’s disease patients.
search

Sign Up to View Cortexyme, Inc.’s Top Employees

Instant access. Cancel anytime

Similar Companies

Start with AroundDeal For Free!

Use AroundDeal to build prospect lists in 1 click.

Instant access. Cancel anytime

Get Contact Info for All Employees

Employees:

static-employee
Una Ryan

Board Member , Lead director

static-employee
Jianhong Wang

Senior Director of Clinical Pharmacology and DMPK

static-employee
MacKenzie Lahar

Senior Manager, Corporate Strategy & Development


static-employee
Shirin Arastu Kapur

Executive Director, Biomarkers and Translational Science

static-employee
Joanna Bolger

Vice President Clinical Operations